What You Should Know:
– Aranscia, a leader in personalized diagnostics, and Signature RX, a prominent pharmacy supplier, announced a collaborative effort to improve the effectiveness of GLP-1 medications.
– The multi-phase partnership focuses on developing…
Continue Reading
Tony Vahedian, CEO at CCS
A report from the Peterson Health Technology Institute (PHTI) found that many digital diabetes management platforms aren’t providing meaningful ROI for patients or the health system as a whole. Users of common…
Continue Reading
What You Should Know:
– CCS — leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions — today announced PropheSee™ a new, AI-powered predictive model for healthcare organizations focused on…
Continue Reading
What You Should Know:
– A new study by Phreesia and the National Kidney Foundation (NKF) reveals a troubling gap in awareness of chronic kidney disease (CKD) among high-risk patients. Published in The American Journal…
Continue Reading
Glucose monitoring specialist Dexcom announced it is expanding its diabetes management capabilities by offering direct connectivity to the Apple Watch of its G7 continuous glucose monitoring system through a dedicated Bluetooth connection.The feature allows…
Continue Reading
Rumah Sakit Universitas Indonesia to test South Korean AI-powered diabetes management appKakao Healthcare has signed a memorandum of agreement with state university hospital Rumah Sakit Universitas Indonesia (RSUI) to pilot its latest AI-based diabetes…
Continue Reading
What You Should Know:
– Tandem Diabetes Care (TNDM) and Dexcom (DXCM) announced today that the Tandem Mobi insulin pump with Control-IQ technology is now compatible with both the Dexcom G7 and Dexcom G6 Continuous…
Continue Reading
What You Should Know:
– A new study suggests that a weekly treatment with semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, may significantly reduce the risk of kidney failure and other complications in patients with…
Continue Reading
What You Should Know:
– Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence…
Continue Reading
By Shania Kennedy
May 14, 2024 – A research team from the University of Virginia (UVA) Center for Diabetes Technology has demonstrated that incorporating AI into an artificial pancreas system for regulating type 1 diabetes improves…
Continue Reading
